Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor
- PMID: 17599916
- DOI: 10.1074/jbc.M704739200
Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor
Abstract
AMD3465 is a novel, nonpeptide CXCR4 antagonist and a potent inhibitor of HIV cell entry in that one of the four-nitrogen cyclam rings of the symmetrical, prototype bicyclam antagonist AMD3100 has been replaced by a two-nitrogen N-pyridinylmethylene moiety. This substitution induced an 8-fold higher affinity as determined against (125)I-12G5 monoclonal CXCR4 antibody binding, and a 22-fold higher potency in inhibition of CXCL12-induced signaling through phosphatidylinositol accumulation. Mutational mapping of AMD3465 and a series of analogs of this in a library of 23 mutants covering the main ligand binding pocket of the CXCR4 receptor demonstrated that the single cyclam ring of AMD3465 binds in the pocket around AspIV:20 (Asp(171)), in analogy with AMD3100, whereas the N-pyridinylmethylene moiety mimics the other cyclam ring through interactions with the two acidic anchor-point residues in transmembrane (TM)-VI (AspVI:23/Asp(262)) and TM-VII (GluVII:06/Glu(288)). Importantly, AMD3465 has picked up novel interaction sites, for example, His(281) located at the interface of extracellular loop 3 and TM-VII and HisIII:05 (His(113)) in the middle of the binding pocket. It is concluded that the simple N-pyridinylmethylene moiety of AMD3465 substitutes for one of the complex cyclam moieties of AMD3100 through an improved and in fact expanded interaction pattern mainly with residues located in the extracellular segments of TM-VI and -VII of the CXCR4 receptor. It is suggested that the remaining cyclam ring of AMD3465, which ensures the efficacious blocking of the receptor, in a similar manner can be replaced by chemical moieties allowing for, for example, oral bioavailability.
Similar articles
-
Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.J Biol Chem. 2004 Jan 23;279(4):3033-41. doi: 10.1074/jbc.M309546200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14585837
-
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.J Biol Chem. 2001 Apr 27;276(17):14153-60. doi: 10.1074/jbc.M010429200. Epub 2001 Jan 11. J Biol Chem. 2001. PMID: 11154697
-
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.Biochem Pharmacol. 2005 Sep 1;70(5):752-61. doi: 10.1016/j.bcp.2005.05.035. Biochem Pharmacol. 2005. PMID: 16011832
-
The bicyclam AMD3100 story.Nat Rev Drug Discov. 2003 Jul;2(7):581-7. doi: 10.1038/nrd1134. Nat Rev Drug Discov. 2003. PMID: 12815382 Review.
-
Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100.Mini Rev Med Chem. 2005 Sep;5(9):805-24. doi: 10.2174/1389557054867075. Mini Rev Med Chem. 2005. PMID: 16178723 Review.
Cited by
-
CXCR4: from B-cell development to B cell-mediated diseases.Life Sci Alliance. 2024 Mar 22;7(6):e202302465. doi: 10.26508/lsa.202302465. Print 2024 Jun. Life Sci Alliance. 2024. PMID: 38519141 Free PMC article. Review.
-
GPCR Inhibition in Treating Lymphoma.ACS Med Chem Lett. 2022 Feb 15;13(3):358-364. doi: 10.1021/acsmedchemlett.1c00600. eCollection 2022 Mar 10. ACS Med Chem Lett. 2022. PMID: 38239337 Free PMC article.
-
Biological and mutational analyses of CXCR4-antagonist interactions and design of new antagonistic analogs.Biosci Rep. 2023 Dec 22;43(12):BSR20230981. doi: 10.1042/BSR20230981. Biosci Rep. 2023. PMID: 38131305 Free PMC article.
-
CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors.Molecules. 2023 Jun 12;28(12):4707. doi: 10.3390/molecules28124707. Molecules. 2023. PMID: 37375261 Free PMC article. Review.
-
Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands.Molecules. 2023 Jan 24;28(3):1156. doi: 10.3390/molecules28031156. Molecules. 2023. PMID: 36770826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information
Medical